Heart Transplants From HCV-Positive Donors Safe
Adult heart transplants from hepatitis C virus-positive donors appear safe, with no increased risk for adverse effects on one-year survival.
Hepatitis C
Nurses Can Help Manage Drug Interactions in HIV/HCV Treatment
Drug interactions between ART and direct-acting antivirals pose a clinical challenge in patients with HIV/hepatitis C virus coinfection.
Outcomes of Hep C Screening Intervention Examined
A multicomponent intervention can improve hepatitis C virus screening, although there is considerable variation by practice.
Renal Impairment Labeling Updates for Sofosbuvir-Based HCV Therapies
The FDA has approved updated labeling for Epclusa, Harvoni and Vosevi to include updated information regarding treatment of patients with HCV who have severe renal impairment including those with end stage renal disease who are on dialysis.
Treatment Response Rates High for Seniors With Hepatitis C Infection
For patients with chronic hepatitis C infection, sustained viral response rates are similar for those aged 65 years and older and those younger than 65.
Lower Education, Hepatitis C Co-Infection Linked to Earlier Menopause in HIV
In women with HIV, lower education and hepatitis C co-infection are independently associated with the onset of menopause before age 45 years.
Women of Reproductive Age: An Important Opportunity to Curtail the HCV Epidemic
Investigators found data from the National Notifiable Diseases Surveillance System that showed hepatitis C virus infection rates doubled among women of reproductive age between 2006 and 2014.
HIV/HCV Co-Infected Children May Significantly Benefit From Early DAA Treatment
Children who are co-infected with HIV and hepatitis C virus may benefit from early treatment with direct acting antivirals
Conflict-Driven Migration Increases Hepatitis Burden as Production Costs Fall
Researchers of studies on the effect of conflict-driven migration on rates of hepatitis indicate that mass migration from high-burden countries has significantly increased the prevalence of both hepatitis C virus (HCV) and hepatitis B virus (HBV) infection in the host nation.
DAA Therapy Associated With Higher Survival in HCV-Related Comorbidities
Patients with hepatitis C virus (HCV) and comorbidities, including hepatocellular carcinoma (HCC), clinically significant portal hypertension, and cirrhosis were shown to have significantly higher survival rates when treatment included directly acting antiviral agent (DAA) therapy, according to the results of several studies presented at the American Association for the Study of Liver Diseases’ The Liver…
Next post in Hepatitis
